Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Haemonetics Corp (NY: HAE ) 84.13 +1.07 (+1.29%) Official Closing Price Updated: 5:00 PM EDT, Jul 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Haemonetics Corp < Previous 1 2 3 4 Next > Looking for growth without the hefty price tag? Consider NYSE:HAE. June 25, 2024 HAEMONETICS CORP/MASS (NYSE:HAE) stands out as a growth opportunity that won't break the bank. Via Chartmill Haemonetics' Strategic Moves Poised To Boost Margins And Earnings, Says Analyst June 12, 2024 Analyst upgrades Haemonetics to Buy, believes company can reach high-20% operating margin goal by FY26 through product mix analysis. Price target set at $112. Via Benzinga This McCormick Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday June 12, 2024 Via Benzinga These 3 Companies Boast Bright Outlooks June 05, 2024 Favorable earnings estimate revisions are key for a stock to move higher. Let’s examine a few highly ranked stocks, including Stride, Interactive Brokers, and Haemonetics. Via Talk Markets NYSE:HAE, a growth stock which is not overvalued. June 03, 2024 Despite its growth, HAEMONETICS CORP/MASS (NYSE:HAE) remains within the realm of affordability. Via Chartmill 12 Health Care Stocks Moving In Tuesday's After-Market Session May 21, 2024 Via Benzinga 4 Analysts Assess Haemonetics: What You Need To Know May 10, 2024 Via Benzinga Earnings Scheduled For February 8, 2024 February 08, 2024 Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. Via Benzinga Is HAEMONETICS CORP/MASS (NYSE:HAE) suited for quality investing? October 09, 2023 Why the quality investor may take a look at HAEMONETICS CORP/MASS (NYSE:HAE). Via Chartmill HAE Stock Earnings: Haemonetics Beats EPS, Beats Revenue for Q4 2024 May 09, 2024 HAE stock results show that Haemonetics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. Via InvestorPlace For those who appreciate growth without the sticker shock, NYSE:HAE is worth considering. April 05, 2024 For those who appreciate growth without the sticker shock, NYSE:HAE is worth considering. Via Chartmill Intuitive Surgical Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark November 17, 2023 Intuitive Surgical stock saw a positive improvement to its Relative Strength (RS) Rating on Friday, with an increase from 74 to 85. Via Investor's Business Daily Intuitive Surgical Stock Rating Climbs As Sales, Profits Rise October 16, 2023 Intuitive Surgical stock got an IBD rating upgrade Monday. It edged up 0.37% to 274.16, its second day in a row of rising share price. Via Investor's Business Daily 10 Health Care Stocks Whale Activity In Today's Session October 10, 2023 Via Benzinga Exploring NYSE:HAE's quality characteristics. September 05, 2023 Should you consider HAEMONETICS CORP/MASS (NYSE:HAE) for quality investing? Via Chartmill Should you consider NYSE:HAE for quality investing? August 10, 2023 HAEMONETICS CORP/MASS (NYSE:HAE) may be suited for quality investing, we'll explore why in this article. Via Chartmill 4 Analysts Have This to Say About Haemonetics August 09, 2023 Via Benzinga Haemonetics Earnings Preview August 07, 2023 Via Benzinga Intuitive Surgical Stock Nearly Doubles; Gets Rating Upgrade September 26, 2023 Intuitive Surgical stock dipped to an intraday low 180.07 in October last year as the bear market ended, then shot up to 358.07 on July 19. Via Investor's Business Daily Haemonetics Corp. (NYSE: HAE) Making Surprising Moves in Monday Session July 17, 2023 Via Investor Brand Network Haemonetics Q4 Earnings Exceed Expectations On Volume And Price Benefits May 11, 2023 Via Benzinga Recap: Haemonetics Q4 Earnings May 11, 2023 Via Benzinga Looking Into Haemonetics's Return On Capital Employed February 08, 2023 Via Benzinga Alphabet To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Wednesday February 08, 2023 Loop Capital boosted the price target for Alphabet Inc. (NASDAQ: GOOGL) from $120 to $125. Loop Capital analyst Rob Sanderson maintained a Buy rating. Alphabet shares fell 3.7% to $103.70 in pre-market... Via Benzinga Earnings Preview: Haemonetics February 06, 2023 Via Benzinga Where Haemonetics Stands With Analysts January 24, 2023 Via Benzinga 9 Analysts Have This to Say About Haemonetics December 12, 2022 Via Benzinga Incyte, Haemonetics Post Earnings Beats; One Surges Within Buy Zone February 07, 2023 Haemonetics stock rose within a buy zone on Tuesday, but Incyte stock toppled. Via Investor's Business Daily How 2022's Biggest Healthcare Gainers Could Fare In 2023 January 06, 2023 Health care stocks were hit hard early in the pandemic but these three have made quite a comeback. This article examines where they could go in 2023 Via MarketBeat Stocks That Hit 52-Week Lows On Thursday December 01, 2022 During Thursday's session, 108 stocks hit new 52-week highs. Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.